HbA1c Testing Device Market to reach US$ 5.69 Billion by 2033, growing at a CAGR of 10.6% | Market Size, Share Analysis, Growth Trends and Forecast 2025-2033 | key Players:- Siemens Healthineers AG, Danaher Corporation, Transasia Biomedicals Ltd.

HbA1c Testing Device Market size reached US$ 2.01 Billion in 2024 and is expected to reach US$ 5.69 Billion by 2033, growing at a CAGR of 10.6% during the forecast period 2025-2033.

The HbA1c testing device market is growing due to rising diabetes prevalence, increasing demand for early diagnosis and routine monitoring, growing adoption of point-of-care testing, technological advancements, and expanding awareness of preventive diabetes management globally.

Download your exclusive free sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/hba1c-testing-device-market?pratik

United States: Key Industry Developments:-
✅ October 2025: Roche Diagnostics expanded its HbA1c testing portfolio with FDA-cleared point-of-care analyzers featuring enhanced accuracy for rapid diabetes monitoring in clinics.​

✅ September 2025: Abbott launched the FreeStyle Libre 3 integrated HbA1c device, combining continuous glucose monitoring with lab-grade A1c results for home use.​

✅ August 2025: Siemens Healthineers upgraded laboratory HbA1c systems with AI-driven automation, improving throughput amid rising diabetes diagnoses.​

Japan: Key Industry Developments:-
✅ October 2025: Arkray introduced a compact HbA1c analyzer for pharmacies, emphasizing portability and quick results to support Japan's aging population diabetes management.​

✅ September 2025: Tosoh Corporation released an advanced HPLC-based HbA1c testing kit with improved precision, aligning with national health screening initiatives.​

✅ August 2025: The Japanese Ministry of Health provided grants for R&D in portable HbA1c devices, boosting local innovation in point-of-care diagnostics

2025 M&A Activity:-
April 2025: Roche Diagnostics acquired a minority stake in a European point-of-care diagnostics company specializing in rapid HbA1c and immunoassay platforms, aiming to strengthen its decentralized diabetes testing portfolio and expand near-patient testing adoption across primary care settings (Q2 2025).

March 2025: Siemens Healthineers completed the acquisition of a U.S.-based clinical diagnostics software and device firm, enhancing data connectivity and automation capabilities across its HbA1c analyzers used in hospital and reference laboratory environments (Q1 2025).

February 2025: Abbott Laboratories acquired a diabetes-focused diagnostic startup with microfluidic HbA1c testing technology, supporting faster turnaround times and broader deployment in physician offices and outpatient clinics (Q1 2025).

Growth Forecast Projection:
The HbA1c Testing Device Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:
Both primary and secondary data sources have been used in the HbA1c Testing Device Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

"Secure your 30% year-end discount - get this report before the offer expires.":https://www.datamintelligence.com/buy-now-page?report=hba1c-testing-device-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

The HbA1c testing device market is experiencing steady growth driven by the rising global prevalence of diabetes and increasing awareness of the importance of glycemic control in diabetes management. HbA1c testing, which provides a reliable measure of average blood glucose levels over the past two to three months, is critical for diagnosing and monitoring diabetes. The market growth is supported by technological advancements in testing devices, including point-of-care (POC) systems that offer quick, accurate results and improved patient compliance.

Additionally, rising healthcare expenditure, growing geriatric populations, and increasing adoption of home-based testing solutions contribute to market expansion. North America currently dominates the market due to established healthcare infrastructure and high awareness levels, while the Asia-Pacific region is poised for rapid growth due to increasing diabetes prevalence and improving healthcare access.

HbA1c Testing Device Major Players:-
Key players are Bio-Rad Laboratories, Inc., Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, EKF Diagnostics Holdings PLC, Arkray, Inc., Trinity Biotech plc, Polymer Technology Systems, Inc., Transasia Biomedicals Ltd.

Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Market segmentation-

By Type
The HbA1c Testing Device Market segments by type primarily into bench-top devices and handheld devices, with bench-top devices holding the dominant market share due to their superior accuracy in clinical environments like hospitals and labs. In recent analyses, point-of-care (POC) devices, often overlapping with handheld types, commanded approximately 76.5% of the market in 2023, driven by demand for rapid testing and patient convenience. Overall market valuations place the POC segment as a leader, contributing significantly to the global size projected at USD 2.34 billion in 2025.​

By Technology
Segmentation by technology includes Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and others, where Ion-Exchange HPLC remains a leading method for its precision in laboratory settings. Specific size breakdowns show these technologies supporting a market expected to grow from USD 2.34 billion in 2025 at a 6.13% CAGR to USD 3.15 billion by 2030, with HPLC and enzymatic assays capturing major shares in high-throughput diagnostics. Affinity and immunoassay methods are gaining traction in POC applications, collectively representing a substantial portion of the technology-driven expansion.​

By Modality
While explicit modality data is limited, the market aligns POC modalities (handheld/portable) against laboratory-based systems, with POC leading at around 76.5% share in aligned type segments for enabling real-time results. Bench-top modalities, suited for centralized labs, maintain a strong presence in the USD 13.92 billion-valued market in 2025, projected to reach USD 22.95 billion by 2033. This split underscores POC's growing dominance, fueled by decentralized healthcare trends

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/hba1c-testing-device-market?pratik

FAQ's-
1. How big is the HbA1c Testing Device Market ?
HbA1c Testing Device Market size reached US$ 2.01 Billion in 2024 and is expected to reach US$ 5.69 Billion by 2033
2: How fast is the HbA1c Testing Device Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 10.6% from 2025 to 2033

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook

This release was published on openPR.